Adial Pharmaceuticals, Inc. ADIL
It has been an absolutely awful end to 2018, with a market bloodbath beginning roughly six weeks ago and amounting to perhaps the worst conditions we’ve seen in a decade. Despite that fact, with most big-board stock hovering at or near their annual lows, we have still managed to find a few plays that have bucked the trend.
One such stock is ADIL, which we signaled a couple weeks back on the morning of the 13th. That day, the stock was trading for as little as 2.55 a share. It has mainly experienced bullish activity even as everything around it has been going the opposite way. On Monday ADIL reached a new high of 5.75, marking a move of 125% in a span of two weeks.
Aemetis, Inc. AMTX
If you’re searching for a bottom play, you won’t have far to look in this market, as we just mentioned above. However, among all these bottom-feeding stocks we’ve got AMTX, which has a compelling reason to perhaps begin to recover some ground.
This morning, the company announced a huge round of non-toxic funding which is going to allow it to begin implementing a key element of its strategy in the New Year. We’re going to place AMTX on watch into 2019, especially with the company having a conference call scheduled for the second week in January. Things could get interesting between now and then thanks to this morning’s news.
CUPERTINO, CA, Dec. 26, 2018 (GLOBE NEWSWIRE) Aemetis, Inc. (AMTX) announced today that its subsidiary, Aemetis Biogas LLC, closed a $30 million equity investment without any dilute stock issuance by Aemetis, Inc. and funded the first $8.3 million tranche to subsidiary Aemetis Biogas to build, own and operate dairy biomethane digesters, pipelines and gas cleanup/compression facilities primarily under 20-year agreements with dairy farms in California (>>View Full PR)
ROKU, ESES, GNMK, CTT, MRIN, TRXC, INPX, HSGX